tradingkey.logo

AVITA Medical Inc <RCEL.OQ> expected to post a loss of 38 cents a share - Earnings Preview

ReutersMay 6, 2025 11:13 PM
  • AVITA Medical Inc RCEL.OQ RCEL.O is expected to show a rise in quarterly revenue when it reports results on May 8 for the period ending March 31 2025

  • The Valencia California California-based company is expected to report a 90.4% increase in revenue to $21.142 million from $11.1 million a year ago, according to the mean estimate from 6 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for AVITA Medical Inc is for a loss of 38 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for AVITA Medical Inc is $17.00​, above​ its last closing price of $9.21. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-0.49

-0.43

-0.44

Missed

-1.6

Sep. 30 2024

-0.44

-0.44

-0.62

Missed

-42.1

Jun. 30 2024

-0.52

-0.52

-0.60

Missed

-15.8​

Mar. 31 2024

-0.45

-0.47

-0.73

Missed

-54.3

​​Dec. 31 2023

-0.36

-0.37

-0.28

Beat

25.2

Sep. 30 2023

-0.45

-0.44

-0.34

Beat

23.4​

Jun. 30 2023

-0.32

-0.32

-0.41

Missed

-26.4

Mar. 31 2023

-0.23

-0.25

-0.37

Missed

-47.4

This summary was machine generated May 6 at 23:13 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI